Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 78.46B P/E 50.78 EPS this Y 6.80% Ern Qtrly Grth 16.70%
Income 1.36B Forward P/E 20.09 EPS next Y 9.10% 50D Avg Chg 7.00%
Sales 19.72B PEG 70.64 EPS past 5Y 1.37% 200D Avg Chg 11.00%
Dividend 1.00% Price/Book 3.05 EPS next 5Y 0.25% 52W High Chg -4.00%
Recommedations 1.90 Quick Ratio 0.78 Shares Outstanding 289.01M 52W Low Chg 28.00%
Insider Own 0.31% ROA 3.20% Shares Float 288.33M Beta 0.47
Inst Own 88.04% ROE 5.37% Shares Shorted/Prior 1.97M/2.31M Price 276.24
Gross Margin 44.56% Profit Margin 6.76% Avg. Volume 1,216,300 Target Price 275.71
Oper. Margin 16.43% Earnings Date Aug 1 Volume 1,396,333 Change -0.83%
About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Becton, Dickinson and Company News
05/17/24 BD's (BDX) FDA-Approved Test to Offer Wider Testing Access
05/15/24 Women in U.S. Can Now Collect Their Own Sample for Cervical Cancer Screening
05/06/24 11 Best Recession Dividend Stocks To Buy
05/04/24 Results: Becton, Dickinson and Company Beat Earnings Expectations And Analysts Now Have New Forecasts
05/03/24 Becton, Dickinson and Company (NYSE:BDX) Q2 2024 Earnings Call Transcript
05/03/24 Becton Dickinson Second Quarter 2024 Earnings: EPS Beats Expectations
05/03/24 Stock Market News for May 3, 2024
05/03/24 Becton Dickinson & Co (BDX) Q2 2024 Earnings Call Transcript Highlights: Strong Growth and ...
05/03/24 Beyond the Balance Sheet: What SWOT Reveals About Becton Dickinson & Co (BDX)
05/02/24 Q2 2024 Becton Dickinson and Co Earnings Call
05/02/24 Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook
05/02/24 Here's Why Becton Dickinson (BDX) is a Strong Value Stock
05/02/24 Compared to Estimates, Becton Dickinson (BDX) Q2 Earnings: A Look at Key Metrics
05/02/24 BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised
05/02/24 Becton Dickinson & Co (BDX) Exceeds Q2 Earnings Estimates and Raises Fiscal 2024 Guidance
05/02/24 Becton Dickinson (BDX) Surpasses Q2 Earnings and Revenue Estimates
05/02/24 Becton Dickinson lifts profit view on strong surgical equipment demand
05/02/24 BD Reports Second Quarter Fiscal 2024 Financial Results
05/01/24 Insider Sale: EVP & President Medical Michael Garrison Sells Shares of Becton Dickinson ...
05/01/24 What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
BDX Chatroom

User Image 11thestate Posted - 3 days ago

The deadline for the $BDX settlement is in two weeks. To check if you are eligible and file for the payout: https://11thestate.com/cases/bdx-shareholder-settlement Recently, $BDX agreed to pay $85M to investors to end claims over software errors with Alaris infusion pumps.

User Image supersleezy Posted - 4 days ago

$BMY $BAX $BDX which one of these do you like 🅱️est? Been buying all 3.

User Image FlawdaBankRoll Posted - 1 week ago

$BDX

User Image proinvstr Posted - 1 week ago

$BDX here is the pop. Locked 70% profit on calls.

User Image proinvstr Posted - 1 week ago

$BDX sitting on technical bullish reversal line and could pop today or tomorrow.

User Image proinvstr Posted - 1 week ago

$DPZ here comes 100% plus, locked, keeping fee runners only for rest of the day. Next loaded up $BDX

User Image 11thestate Posted - 2 weeks ago

$BDX settled $85M with investors to end litigation over software errors with Alaris infusion pumps. Claim submission info and details: https://11thestate.com/cases/bdx-shareholder-settlement

User Image Monkey_Banana_Genius Posted - 3 weeks ago

$BDX What YOs think of this super thick 6 year base? @Doozio @AnchorsAweigh r

User Image DonCorleone77 Posted - 3 weeks ago

$ABT $BDX $ENOV $SYK $TWST Evercore ISI removes several healthcare names from 'Tactical Outperform' list Evercore ISI is removing Abbott (ABT), Becton Dickinson (BDX), Enovis (ENOV), Stryker (SYK), Illumina (ILMN) and Twist Bioscience (TWST) from the firm's "Tactical Outperform" list given that the earnings catalysts have passed. The firm still has Mesa Labs (MLAB), which will be reporting in the next three weeks, on the "Tactical Outperform" list, the analyst noted.

User Image Monkey_Banana_Genius Posted - 3 weeks ago

$BDX wow this stuck has been stuck in mud for 5 years. That’s quite the base. 👀

User Image StockInvest_us Posted - 3 weeks ago

Signal alert: $BDX - PivotPoint bottom https://stockinvest.us/l/AupQkJ5uMs

User Image amberajax2point0 Posted - 3 weeks ago

$BDX volume 3.5mm, average 1.1mm…

User Image amberajax2point0 Posted - 3 weeks ago

$BDX stock 💩 the bed 🛌 mid-day and recovered, size is buying…

User Image 11thestate Posted - 3 weeks ago

$BDX

User Image DonCorleone77 Posted - 3 weeks ago

$BDX Becton Dickinson raises FY24 adjusted EPS $12.95-$13.15 from $12.82-$13.06 Consensus $12.95. Lowers FY24 revenue view to $20.1B-$20.3B from $20.2B-$20.4B, consensus $20.3B. The company said, The company affirmed its fiscal 2024 organic revenue growth guidance range and increased its adjusted diluted earnings per share guidance range which reflects an increase of 11 cents at the midpoint."

User Image epsguid Posted - 3 weeks ago

$BDX reported earnings of $3.17, consensus was $2.96 via @eWhispers #epsbeat http://eps.sh/d/bdx

User Image Stock_Titan Posted - 3 weeks ago

$BDX BD Reports Second Quarter Fiscal 2024 Financial Results https://www.stocktitan.net/news/BDX/bd-reports-second-quarter-fiscal-2024-financial-01vk20b2toat.html

User Image insiderbuyingselling Posted - 3 weeks ago

$BDX new insider selling: 1715 shares. http://insiderbuyingselling.com/?t=BDX

User Image Zedemel Posted - 3 weeks ago

$AXDX here i think something nearer to Chewey. This sums for a big pharma are easy like us buying something on amazon. Otherwise the best monetary option would be let axdx sinking to bankruptcy, paying 70mil to creditors and get the product at zero cost. maybe it happens but I think with dilation of times. My common sense, i think $AXDX and $BDX has already talked about a value for Wave, last year, but who knows.

User Image Stock_Titan Posted - 04/29/24

$BDX BD to Present at Bank of America Securities Health Care Conference 2024 https://www.stocktitan.net/news/BDX/bd-to-present-at-bank-of-america-securities-health-care-conference-u0fnqncp2wqz.html

User Image WhackaMole Posted - 04/29/24

$AXDX IMHO, If I were the head of Biomereiux, I would make a bid for this company to keep the technology away from competitors. At the very least, they would make it much more expensive for $BDX and $RHHBY. Their bankers should start making calls and pitch this to their strategic clients.

User Image MedDeviceEngineer Posted - 1 month ago

$BDX how is this not skyrocketing with the FDA turning off the Syringe supply chain from China? Someone plz educate me

User Image 11thestate Posted - 1 month ago

$BDX Don't delay in claiming this settlement , the deadline is 14 Jun 2024

User Image ClassifiedTrades Posted - 1 month ago

$DXYZ kind of looking to go crazy again ? $WETH $BDX

User Image StockInvest_us Posted - 1 month ago

Signal alert: $BDX - GoldenStar https://stockinvest.us/l/rVJQb5hX6W

User Image DividendPower Posted - 1 month ago

The List of Dividend Champions in 2024 - Updated 04/01/24 https://www.dividendpower.org/list-dividend-champions-2024/ $CTAS $BDX $RPM $UBSI $SYY

User Image Kingkingking Posted - 1 month ago

Yields go higher and stocks tank. Thats how this works $QQQ $SPY $BDX

User Image StockInvest_us Posted - 1 month ago

Signal alert: $BDX - GoldenStar https://stockinvest.us/l/7JCBCC2pMx

User Image StockInvest_us Posted - 1 month ago

Signal alert: $BDX - Overbought Trend Short (Overvalued) https://stockinvest.us/l/Xl85v56qpM

User Image Stock_Titan Posted - 1 month ago

$BDX BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters https://www.stocktitan.net/news/BDX/bd-increases-access-to-cutting-edge-image-enabled-spectral-cell-zgntqdajvs28.html

Analyst Ratings
Barclays Overweight May 6, 24
Barclays Overweight Feb 5, 24
Raymond James Outperform Jan 3, 24
Morgan Stanley Overweight Dec 4, 23
Piper Sandler Overweight Nov 10, 23
Raymond James Outperform Nov 10, 23
Citigroup Neutral Aug 21, 23
Barclays Overweight Aug 7, 23
Morgan Stanley Overweight Aug 4, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Byrd Richard EVP & President Inte.. EVP & President Interventional Nov 28 Sell 238.47 2,156 514,141 4,120 11/29/23
Byrd Richard EVP & President Inte.. EVP & President Interventional Sep 05 Sell 274.48 459 125,986 3,444 09/06/23
Fraser Claire Director Director Aug 28 Sell 281.66 848 238,848 21,608 08/30/23
Garrison Michael David EVP & President Medi.. EVP & President Medical Aug 08 Sell 277.13 1,300 360,269 5,157 08/09/23
Goette Roland EVP and President, E.. EVP and President, EMEA Nov 16 Option 74.94 4,617 345,998 14,896 11/18/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences Aug 15 Sell 265.00 475 125,875 3,331 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Option 167.91 15,000 2,518,650 43,878 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Sell 265.13 9,500 2,518,735 28,878 08/17/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Sell 260 443 115,180 1,058 06/09/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Option 147.68 1,026 151,520 2,070 06/09/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences May 06 Sell 256 475 121,600 3,806 05/10/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Option 193.09 46,658 9,009,193 9,556 02/28/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Sell 271.9 14,374 3,908,291 5,872 02/28/22
Fraser Claire Director Director Feb 08 Sell 271.70 841 228,500 21,556 02/10/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Option 134.73 12,787 1,722,793 34,047 02/07/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Sell 270.16 6,410 1,731,726 21,260 02/07/22
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Sell 257.44 6,956 1,790,753 19,768 09/07/21
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Option 134.73 14,584 1,964,902 34,352 09/07/21